Finding 980268 (2022-004)

Material Weakness Repeat Finding
Requirement
A
Questioned Costs
$1
Year
2022
Accepted
2024-06-28

AI Summary

  • Core Issue: Unsupported expenses totaling $31,721.92 were reported, lacking necessary documentation to verify their legitimacy.
  • Impacted Requirements: Compliance with 45 CFR § 75.403 was not met, as costs must be necessary, reasonable, and adequately documented.
  • Recommended Follow-Up: Implement a tracking system for grant expenses and ensure all supporting documents are retained and accessible, along with regular reconciliations of reports and accounting records.

Finding Text

#2022-004 – Material Weakness – Activities Allowed or Unallowed, Reporting, Cash Management, Period of Performance Opioid STR Grant ALN 93.788 Block Grants for Prevention and Treatment of Substance Abuse 93.959 Criteria The Office of Management and Budget issuance of the Code of Federal Regulations (CFR) specifically states uniform administrative requirements, cost principles, and audit requirements for federal awards. In accordance with 45 CFR § 75.403, “Except where otherwise authorized by statute, costs must meet the following general criteria in order to be allowable under Federal awards: (a) be necessary and reasonable for the performance (b) Conform to any limitations or exclusions set forth in these principles or in the Federal award as to types or amount of cost items. **** (g) Be adequately documented.” Condition During the audit we noted the Organization reported the following expenses that were not supported by the accounting records or supporting documentation: For the monthly reports tested, we were unable to examine supporting invoices or supporting documentation for $31,721.92 of the $90,546.79 charges reviewed. Additionally, for these items, because invoices or other support was not available, we were unable to verify the service period and whether the expense was charged to the correct grant period. Cause The cause is a lack of a proper control structure that includes retention of all supporting documentation for expenses and proper tracking of expenses charged to the grant programs. Effect The potential effects are overbilling the grant program and unsupported charges. Questioned Costs $149,061 Perspective Information We reviewed a sample of reports filed with the Pennsylvania Department of Military and Veterans Affairs and the Drug and Alcohol Program. We examined the payroll for each employee charged to the grant for a total of twenty-six employees. We also tested nonpayroll related expenses charged to the grant. The finding represents the unsupported costs noted from this review. Identification as a repeat finding A similar issue was noted in prior year finding #2021-004. **** - Citations not pertinent to this finding. Recommendation We recommend that the Organization develop a system to track all expenses charged to each grant contract by month and systematically file all supporting documentation in a manner that can easily be accessed. This information must be retained in accordance with the Federal and grant guidelines. The monthly reports filed for the grants should be supported by the Organization’s accounting records and invoices. We further recommend that the Organization perform a reconciliation between the monthly reports and the accounting records.

Categories

Questioned Costs Allowable Costs / Cost Principles

Other Findings in this Audit

  • 403816 2022-001
    Material Weakness Repeat
  • 403817 2022-002
    Material Weakness Repeat
  • 403818 2022-003
    Material Weakness Repeat
  • 403819 2022-004
    Material Weakness Repeat
  • 403820 2022-005
    Material Weakness Repeat
  • 403821 2022-006
    Material Weakness Repeat
  • 403822 2022-007
    Significant Deficiency Repeat
  • 403823 2022-001
    Material Weakness Repeat
  • 403824 2022-002
    Material Weakness Repeat
  • 403825 2022-003
    Material Weakness Repeat
  • 403826 2022-004
    Material Weakness Repeat
  • 403827 2022-005
    Material Weakness Repeat
  • 403828 2022-006
    Material Weakness Repeat
  • 403829 2022-007
    Significant Deficiency Repeat
  • 980258 2022-001
    Material Weakness Repeat
  • 980259 2022-002
    Material Weakness Repeat
  • 980260 2022-003
    Material Weakness Repeat
  • 980261 2022-004
    Material Weakness Repeat
  • 980262 2022-005
    Material Weakness Repeat
  • 980263 2022-006
    Material Weakness Repeat
  • 980264 2022-007
    Significant Deficiency Repeat
  • 980265 2022-001
    Material Weakness Repeat
  • 980266 2022-002
    Material Weakness Repeat
  • 980267 2022-003
    Material Weakness Repeat
  • 980269 2022-005
    Material Weakness Repeat
  • 980270 2022-006
    Material Weakness Repeat
  • 980271 2022-007
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $1.16M
93.959 Block Grants for Prevention and Treatment of Substance Abuse $615,643